Journal of Virology · 2013 · 95 citations · 25 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityImmunology Of Infectious DiseasesVaccinologyAntibody CharacterizationAntigen RecognitionCell-mediated ImmunityHumoral ImmunityViral VaccinesYellow FeverCd4 Positive T Cell ResponsesCd4 Positive T CellsEpitope SpecificityHla AllelesT-cell EpitopesT-cell Immune ResponsesYellow Fever VaccinationYellow Fever Virus
Yellow fever virus (YFV) can induce acute, life-threatening disease that is a significant health burden in areas where yellow fever is endemic, but it is preventable through vaccination. The live attenuated 17D YFV strain induces responses characterized by neutralizing antibodies and strong T cell responses. This vaccine provides an excellent model for studying human immunity. While several studies have characterized YFV-specific antibody and CD8(+) T cell responses, less is known about YFV-specific CD4(+) T cells. Here we characterize the epitope specificity, functional attributes, and dynamics of YFV-specific T cell responses in vaccinated subjects by investigating peripheral blood mononuclear cells by using HLA-DR tetramers. A total of 112 epitopes restricted by seven common HLA-DRB1 alleles were identified. Epitopes were present within all YFV proteins, but the capsid, envelope, NS2a, and NS3 proteins had the highest epitope density. Antibody blocking demonstrated that the majority of YFV-specific T cells were HLA-DR restricted. Therefore, CD4(+) T cell responses could be effectively characterized with HLA-DR tetramers. Ex vivo tetramer analysis revealed that YFV-specific T cells persisted at frequencies ranging from 0 to 100 cells per million that are detectable years after vaccination. Longitudinal analysis indicated that YFV-specific CD4(+) T cells reached peak frequencies, often exceeding 250 cells per million, approximately 2 weeks after vaccination. As frequencies subsequently declined, YFV-specific cells regained CCR7 expression, indicating a shift from effector to central memory. Cells were typically CXCR3 positive, suggesting Th1 polarization, and produced gamma interferon and other cytokines after reactivation in vitro. Therefore, YFV elicits robust early effector CD4(+) T cell responses that contract, forming a detectable memory population.
25
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Troy D. Querec, Rama Akondy, Eva K. Lee et al. · Nature Immunology · 2008 · 1.1K citations · Full text
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
Joseph D. Miller, Robbert van der Most, Rama Akondy et al. · Immunity · 2008 · 613 citations · Full text
Troy D. Querec, Soumaya Bennouna, Sefik Alkan et al. · The Journal of Experimental Medicine · 2006 · 546 citations · Full text